Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose oral cannabidiol crossover study in healthy male volunteers using PainCart and NeuroCart
NL-OMON49760Phase 2Withdrawn
- Sponsor
- Centre for Human Drug Research
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol (3 arms), sponsored by Centre for Human Drug Research. Planned start Aug 2020; status: withdrawn.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NL-OMON49760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49760.